Cosmo Pharmaceuticals NV
SIX:COPN
Wall Street
Price Targets
COPN Price Targets Summary
Cosmo Pharmaceuticals NV
According to Wall Street analysts, the average 1-year price target for
COPN
is 91.19 CHF
with a low forecast of 76.76 CHF and a high forecast of 114.45 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is COPN's stock price target?
Price Target
91.19
CHF
According to Wall Street analysts, the average 1-year price target for
COPN
is 91.19 CHF
with a low forecast of 76.76 CHF and a high forecast of 114.45 CHF.
What is Cosmo Pharmaceuticals NV's Revenue forecast?
Projected CAGR
32%
For the last 8 years the
compound annual growth rate for
Cosmo Pharmaceuticals NV's revenue is
6%.
The projected
CAGR
for the next 3 years is
32%.
What is Cosmo Pharmaceuticals NV's Operating Income forecast?
Projected CAGR
102%
The
compound annual growth rate
of Cosmo Pharmaceuticals NV's operating income for the next 3 years is
102%.
What is Cosmo Pharmaceuticals NV's Net Income forecast?
Projected CAGR
297%
For the last 8 years the
compound annual growth rate for
Cosmo Pharmaceuticals NV's net income is
-49%.
The projected
CAGR
for the next 3 years is
297%.
You don't have any saved screeners yet
